Preview
The range of cholesterol levels considered normal has been revised downward in the past decade. The new, lower standards have created a need for more aggressive treatment. Dr Rackley reviews the study findings that form the basis for current recommendations and examines the capability of lipid-lowering agents, especially HMG-CoA reductase inhibitors, to reduce cholesterol levels and, ultimately, the incidence of cardiovascular events.